CynergisTek Signs Six-Figure Extension Contract with Nationally Ranked Hospital
“I have no doubt that this will continue to be a strong partnership with this client, and we are pleased to expand on offering our custom staffing remediation services,” said Mac McMillan, President, and CEO of CynergisTek.
Global Overview of the Market for Spectroscopy Devices for Monitoring Patient Glucose Levels – ResearchAndMarkets.com
What you will learn from this report. Read on.
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
Omeros received approximately $126 million in cash at closing. In addition, Omeros retains and is entitled to collect the full amount of its accounts receivable outstanding as of today’s closing.
Powered by MRP Announces Exclusive Agreement with LUVO Medical
MRP founder and CEO Scott Carson stated, "This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time."
Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults
"Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally. Molnupiravir is limited to situations where other FDA-authorized treatments for COVID-19 are inaccessible or are not clinically appropriate and will be a useful treatment option for some patients with COVID-19 at high risk of hospitalization or death," said Patrizia Cavazzoni, M.D., director of the FDA's Center for Drug Evaluation and Research. "As new variants of the virus continue to emerge, it is crucial to expand the country's arsenal of COVID-19 therapies using emergency use authorization, while continuing to generate additional data on their safety and effectiveness."